Stem Cell Innovations logo
Website

Stem Cell Innovations

ICO

Stem Cell Innovations focuses on research and development in the field of stem cell science, with the dual purposes of furthering human longevity and expanding access to stem cell treatments through cutting-edge technology.

IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice.

Overview

Product typeApp
WhitepaperStem Cell Innovations White Paper Open

What is Stem Cell Innovations

The Stem Cell Innovations (SCI) team claim that their solution will run on two blockchain platforms. The first platform will be built on Ethereum and will be used only for ERC20 tokens. The second custom blockchain will be developed by the SCI engineers specifically for the healthcare environment. Via the SCI app users will be able to buy cord blood services, purchase medical supplies, acquire synthetic stem cells, etc. The ERC20 SCIA tokens will be used to access and pay for the platform services.

Details

Pre-sales: Sep 17, 2018 - Oct 29, 2018
Public sales: Nov 21, 2018 - Jan 17, 2019
Token supply: 240,000,000
Soft cap: 3,000,000USD (fiat)
Hard cap: 36,000,000 USD(fiat)

Legal

Country limitations: China, Cuba, Iran, Syria, United States, North Korea,
Registration country: Gibraltar

Token info

Ticker: SCIA
Type: Utility-token
Token price in USD: 1 SCIA = 0.15 USD
Accepted currencies: ETH BTC LTC USD EUR
Bonus program:
Pre-Sale Bonuses:
Day 1-7: 60% bonus
Day 8-14: 55% bonus
Day 15-21: 50% bonus
Day 22-28: 45% bonus
Day 29-42: 40% bonus
Main-Sale Bonuses:
Day 43-54: 30% bonus
Day 55-69: 25% bonus
Day 70-End: 15% bonus
Funds allocation:
22% - Marketing & Sales
18% - Infrastructure and Project Management
18% - Team and Advisors
15% - IT Development & R&D
11% - International Expansion and Partnership of Stem Labs
9% - Legal
5% - Reserve
2% - Lobbuing Stem Cell USFDA

Stem Cell Innovations Roadmap

1
2013

Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.

2
Q4 2017

Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.
Advanced research begins to determine market and development opportunities.

3
Q1 2018

Attended Token 2049 conference in Hong Kong.
Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).
Attended CBC conference in San Francisco, CA.

4
Q2 2018

Attended ICO20 Summit in Santa Monica, CA.
Integration of smart contract technology is established.
Company headquarters incorporated in Gibraltar, GB.
Strategic efforts toward development begins.
Interviews with potential medical participants take place.

5
Q3 2018

Whitelist is scheduled to go live.
Token Sale starts.

6
Q4 2018

Token Sale ends and min max caps are assessed.
Distribution of Tokens to participants through ERC20 will commence.

7
Q1 2019

SCI will begin final testing and reporting based on blockchain technology being used.
Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.
Demo testing for SCI Application v 1.0 will begin.

8
Q2 2019

Release of the SCI Application v1.1
Enrollment begins for doctors, patients, and stem cell laboratories in the United States

9
Q3 2019

Release of Market Surveillance strategy for further growth
Release SCI Application v2.0
Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.
Announcement of first SCI Lab location and franchise expansion plan.

10
Q4 2019

Announcement of clinical development and research strategy in the stem cell field.
Public announcement regarding SCI achievements to date.
First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.

11
Q1 2020

Stem Cell Lab Evaluation report per first year of operation and development.
Release SCI earnings and financials report.
Release results of SCI's stem cell research and development to date.

12
Q2 2020

Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.
Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.

13
Q3 2020

Begin second phase of SCI stem cell research and development.
Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.

14
Q4 2020

Expansion and acquisition of SCI stem cell labs and clinics in Europe.

15
Q1 2021

Release SCI earnings and financials report for second year operation and development.
Release public update on SCI stem cell research and development.
Stem Cell Lab Evaluation report for second year.

16
Q2 2021

Release SCI Application v4.0 including:
A new platform for medical students, universities, and hospitals to engage with the SCI Application.
Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.

Project team

Moe Galal
Moe Galal
Chief Executive Officer / Founder
Moe Galal linkedin
Ben Barel
Ben Barel
Chief Operations Officer / Co-Founder
Ben Barel linkedin
Ali Alrashidi
Ali Alrashidi
Chief Technology Officer / Co-Founder
Ali Alrashidi linkedin
Matt Galal
Matt Galal
Chief of Staff / Co-Founder
Matt Galal linkedin
Kobi Barel
Kobi Barel
Operations Engineer / Co-Founder
Kobi Barel linkedin
John Glavinovich, M.D.
John Glavinovich, M.D.
Medical Director
John Glavinovich, M.D. linkedin
Philip Glukhovsky, D.C.
Philip Glukhovsky, D.C.
Health Informatics Manager
Philip Glukhovsky, D.C. linkedin
Roger Williams
Roger Williams
VP of Marketing
Roger Williams linkedin
Liz Curlett
Liz Curlett
VP, PR & Corporate Communications
Liz Curlett linkedin
Candice Kouchache
Candice Kouchache
Business Development
Candice Kouchache linkedin
Ahmed Elsantawi
Ahmed Elsantawi
VP of International Human Resources
Ahmed Elsantawi linkedin
David Marmon
David Marmon
Web Designer
David Marmon linkedin
Heather Deveaux
Heather Deveaux
Copywriter
Heather Deveaux linkedin
Everlecia Taylor
Everlecia Taylor
Creative Writer
Everlecia Taylor linkedin
Marina Evglevskaya
Marina Evglevskaya
Administrative Manager
Marina Evglevskaya linkedin
Rakel Apodaca
Rakel Apodaca
Product Manager
Rakel Apodaca linkedin
Michelle Chavon
Michelle Chavon
Marketing
Michelle Chavon linkedin

Advisors

Boyan Josic
Boyan Josic
Boyan Josic linkedin
Marc X. Ellul
Marc X. Ellul
Marc X. Ellul linkedin
Roger Shortz, M.D.
Roger Shortz, M.D.
Roger Shortz, M.D. linkedin
Greg Maddex, D.O
Greg Maddex, D.O
Greg Maddex, D.O linkedin

Social media

Stem Cell Innovations web-siteStem Cell Innovations RedditStem Cell Innovations MediumStem Cell InnovationsYouTubeStem Cell Innovations TelegramStem Cell Innovations InstagramStem Cell Innovations LinkedInStem Cell Innovations TwitterStem Cell Innovations Facebook

Increase your Conversion Rate

Add our widget to your website and make an announcement of the listing in your social media

Horizontal
Square
Light
Dark
Height: 50 px
Width: 160 px

Leave a Reply

Your email address will not be published. Required fields are marked *

Sponsored Crypto Projects